Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation

Blood

Volumn 98, Issue 7, 2001, Pages 2059-2064

  Narayanasami, Uma ^a   Kanteti, Rajani ^a   Morelli, Julie ^a   Klekar, Alanna ^a   Al Olama, Asma ^a   Keating, Claire ^a   O'Connor, Colleen ^a   Berkman, Eugene ^a   Erban, John K ^a   Sprague, Kellie A ^a   Miller, Kenneth B ^a   Schenkein, David P ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; ETOPOSIDE; PREDNISONE; PROCARBAZINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; AUTOTRANSPLANTATION; CELL MIGRATION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL; HUMAN; LYMPHOMA; MALE; NEUTROPHIL; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZATION; RELAPSE; SALVAGE THERAPY; SURVIVAL RATE;

EID: 0035496919     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.7.2059     Document Type: Article

References (34)

1. Schmitz N, Linch DC, Dreger P, et al. Randomized trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet. 1996;347:353-357.
2. Stockerl-Goldstein KE, Horning SJ, Negrin RS, et al. Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplant for non-Hodgkin's lymphoma. Biol Blood Marrow Transplant. 1996;2:76-85.
3. Whetton AD, Graham GJ. Trends: homing and mobilization in the stem cell niche. Cell Biol. 1999;9:233-238.
4. Shizuru JA, Weissman IL. Isolation and characterization of hematopoietic stem cells. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation. 2nd ed. Boston, MA: Blackwell Science; 1999:63-78.
5. DOhrsen U, Villeval JL, Boyd J, et al. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood. 1988;72:2074-2081.
6. Socinski MA, Cannistra SA, Elias A, et al. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet. 1988;1:1194-1198.
7. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD. Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells. Exp Hematol. 1986; 14:192-196.
8. Hohaus S, Goldschmidt H, Ehrhardt R, et al. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol. 1993;21:508-514.
9. Shimazaki C, Oku N, Ashihara E, et al. Collection of peripheral blood stem cells mobilized by highdose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor. Bone Marrow Transplant. 1992;10:341-346.
10. Akard LP. Optimum methods to mobilize stem cells. J Clin Oncol. 2000;18:3063.
11. + cells with a different antigenic profile compared with use during steady-state hematopoiesis. Bone Marrow Transplant. 1994; 14:827-832.
12. Koc ON, Gerson SL, Cooper BW, et al. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF. J Clin Oncol. 2000;18:1824-1830.
13. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood. 1997;89:2233-2258.
14. + cell collections are not necessarily cost-effective. Biol Blood Marrow Transplant. 1999;5:379-385.
15. Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute-sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer. 1982;49: 2112-2135.
16. Malachowski M, Comenzo R, Hillyer C, et al. Large volume leukapheresis for peripheral blood stem cell collection in patients with hematological malignancies. Transfusion. 1992;32:732-735.
17. Comenzo R, Malachowski M, Miller K, et al. Engraftment with peripheral blood stem cells collected by large volume leukapheresis for patients with lymphoma. Transfusion. 1992;32:729-731.
18. Laskey LC, Ash RC, Kersey JH, Zanjani ED, McCullough J. Collection of pluripotential hematopoietic stem cells by cytapheresis. Blood. 1982; 59:822-827.
19. McCann J, Kanteti R, Shilepsky B, Miller K, Sweet M, Schenkein D. High degree of occult tumor contamination in bone marrow and peripheral blood stem cells of patients undergoing autologous transplantation for non-Hodgkin's lymphoma. Biol Blood Marrow Transplant. 1996; 2:37-43.
20. Kanteti R, Miller KB, McCann JC, et al. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for highdose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis. Bone Marrow Transplant. 1999;24:473-481.
21. Barker RL, Worth CA, Peiper SC. Cytometric detection of DNA amplified with fluorescent primers: applications to analysis of clonal bcl-2 and IgH gene rearrangements in malignant lymphomas. Blood. 1994;83:1079-1085.
22. Coates PJ, d'Ardenne AJ, Khan G, Kangro HO, Slavin G. Simplified procedures for applying the polymerase chain reaction to routinely fixed paraffin wax sections. J Clin Palhol. 1991;44:115-118.
23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
24. Cox DR. Regression models and life tables. J R Stat Soc [B]. 1972;34:187-220.
25. + cells and rapid recovery after peripheral blood stem cell transplantation. J Clin Oncol. 1995;13:1922-1932.
26. Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol. 2000;18:1360-1377.
27. + cells is related to hematopoietic recovery after autologous transplantation. Blood. 2001;97:799-804.
28. Peled A, Petit A, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR-4. Science. 1999;283: 845-848.
29. Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ. Mobilization of hematopoietic progenitor cells into peripheral blood associated with VCAM-1 proteolytic cleavage in the bone marrow [abstract]. Blood. 2000;96:221.
30. Vescio R, Berenson J. Autologous transplantation: purging and the impact of minimal residual disease. Hematol/Oncol Clin North Am. 1999;13:969-986.
31. Passos Coelho JL, Ross AA, Kahn DJ, et al. Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor. J Clin Oncol. 1996;14:2569-2575.
32. + cells to remove circulating tumor cells. Blood. 1996;87:1625-1634.
33. Kobbe G, Sohngen D, Bauser U. Factors influencing G-CSF-mediated mobilization of hematopoietic progenitor cells during steady-state hematopoiesis in patients with malignant lymphoma and multiple myeloma. Ann Hematol. 1999;78: 456-462.
34. Akard LP, Wiemann M, Thompson J, et al. Impaired stem cell collection by consecutive courses of high-dose mobilizing chemotherapy using cyclophosphamide, etoposide and G-CSF. J Hematother. 1996;5:271-277.